KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 65 filers reported holding KALVISTA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,650,350 | +12.6% | 275,218 | +5.2% | 0.00% | – |
| Q2 2023 | $2,354,544 | +26.9% | 261,616 | +10.8% | 0.00% | – |
| Q1 2023 | $1,855,848 | +13.5% | 236,113 | -2.4% | 0.00% | – |
| Q4 2022 | $1,635,670 | -53.9% | 241,963 | -1.1% | 0.00% | -100.0% |
| Q3 2022 | $3,550,000 | +47.7% | 244,696 | +0.2% | 0.00% | 0.0% |
| Q2 2022 | $2,404,000 | -34.1% | 244,218 | -1.4% | 0.00% | 0.0% |
| Q1 2022 | $3,650,000 | +8.2% | 247,676 | -2.8% | 0.00% | 0.0% |
| Q4 2021 | $3,372,000 | -17.3% | 254,909 | +9.1% | 0.00% | 0.0% |
| Q3 2021 | $4,079,000 | -29.6% | 233,740 | -3.3% | 0.00% | 0.0% |
| Q2 2021 | $5,794,000 | -1.4% | 241,833 | +5.8% | 0.00% | 0.0% |
| Q1 2021 | $5,875,000 | +35.0% | 228,670 | -0.3% | 0.00% | 0.0% |
| Q4 2020 | $4,353,000 | +44.7% | 229,244 | -4.0% | 0.00% | 0.0% |
| Q3 2020 | $3,008,000 | +2.7% | 238,896 | -1.4% | 0.00% | 0.0% |
| Q2 2020 | $2,930,000 | +102.3% | 242,193 | +28.0% | 0.00% | – |
| Q1 2020 | $1,448,000 | -56.2% | 189,283 | +1.9% | 0.00% | -100.0% |
| Q4 2019 | $3,308,000 | +59.7% | 185,769 | +4.1% | 0.00% | – |
| Q3 2019 | $2,072,000 | +26.7% | 178,521 | +141.8% | 0.00% | – |
| Q2 2019 | $1,635,000 | +39.7% | 73,830 | +80.5% | 0.00% | – |
| Q1 2019 | $1,170,000 | +45.3% | 40,900 | +0.4% | 0.00% | – |
| Q4 2018 | $805,000 | +18.7% | 40,728 | +32.7% | 0.00% | – |
| Q3 2018 | $678,000 | – | 30,694 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 719,937 | $6,697,459 | 5.56% |
| TCG Crossover Management, LLC | 3,395,495 | $22,953,546 | 4.05% |
| VR Adviser, LLC | 2,916,667 | $19,716,669 | 3.32% |
| TANG CAPITAL MANAGEMENT LLC | 3,196,446 | $21,607,975 | 3.14% |
| Prosight Management, LP | 621,667 | $4,202,469 | 2.29% |
| Opaleye Management Inc. | 923,200 | $6,240,832 | 2.17% |
| GREAT POINT PARTNERS LLC | 1,055,801 | $7,137,215 | 1.40% |
| Frazier Life Sciences Management, L.P. | 3,238,859 | $21,894,687 | 1.36% |
| DAFNA Capital Management LLC | 616,032 | $4,164,376 | 1.17% |
| Vivo Capital, LLC | 856,008 | $5,787 | 0.67% |